Visa, AMD and Thermo Fisher Scientific headline Zacks' top analyst reports, spotlighting digital payments strength, AI-driven ...

TMO heads into Q4 earnings with Specialty Diagnostics growth, fresh FDA approvals and launches that could lift results on Jan ...

"Not only do I live here, but I also know most of our key clients are located in the Triangle area," the CEO said about the ...

The global transplant diagnostics market, valued at USD 3.9 billion in 2021, is anticipated to grow at a CAGR of 7.40%, reaching approximately USD 6.4 billion by 2028. This growth is driven by ...

The growth of the Relational Databases Software Market is primarily driven by the exponential rise in enterprise data volumes, increasing adoption of cloud-based database solutions, and the ...

As the earnings season gains momentum, the upcoming week is set to deliver one of the most closely watched stretches of ...

Segun Idowu, who has served as Mayor Michelle Wu’s economic development chief since she entered office, is resigning from his ...

The market is ripe for growth driven by pharma outsourcing to CDMOs, emphasizing advanced drug products and integrated ...

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

Qiagen is reviewing strategic options, including a potential sale, after renewed takeover interest from several buyers.

NAV still ~$6/share above enterprise value after sales. Asset sales may boost returns. Click for this NLOP update.